Sen. Cassidy calls for FDA to adapt to post-Chevron world

Sen. Bill Cassidy has requested detailed information from FDA about how it will respond to the Supreme Court’s decision to overturn Chevron deference. In a letter to FDA Commissioner Rob Califf, Cassidy cited examples of FDA actions he believes should be reconsidered in light of the ruling, including the agency’s assertion of authority to regulate laboratory developed tests and its decision to sidestep a federal court’s decision on orphan drug exclusivity.

Cassidy (R-La.), the ranking member of the Health, Education, Labor and Pensions (HELP) Committee, is in line to become chair of the powerful committee if Republicans gain a majority in the Senate in November. ...